ResMed Inc. (0KW4.L)
USD 213.58
(0.45%)
USD 213.58
(0.45%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.36 Billion USD | 10.95% |
| 2023 | 1.2 Billion USD | 17.54% |
| 2022 | 1.02 Billion USD | 10.5% |
| 2021 | 926.74 Million USD | 1.98% |
| 2020 | 908.72 Million USD | 0.9% |
| 2019 | 900.59 Million USD | 12.31% |
| 2018 | 801.9 Million USD | 7.64% |
| 2017 | 745.01 Million USD | 19.17% |
| 2016 | 625.16 Million USD | 4.87% |
| 2015 | 596.16 Million USD | 3.08% |
| 2014 | 578.37 Million USD | -1.27% |
| 2013 | 585.83 Million USD | 11.52% |
| 2012 | 525.32 Million USD | 10.97% |
| 2011 | 473.4 Million USD | 14.88% |
| 2010 | 412.1 Million USD | 14.48% |
| 2009 | 359.99 Million USD | 3.33% |
| 2008 | 348.4 Million USD | 18.37% |
| 2007 | 294.32 Million USD | 20.39% |
| 2006 | 244.47 Million USD | 46.31% |
| 2005 | 167.08 Million USD | 27.18% |
| 2004 | 131.37 Million USD | 24.12% |
| 2003 | 105.84 Million USD | -42.49% |
| 2002 | 184.05 Million USD | 201.44% |
| 2001 | 61.06 Million USD | 18.03% |
| 2000 | 51.73 Million USD | 34.37% |
| 1999 | 38.5 Million USD | 29.19% |
| 1998 | 29.8 Million USD | 28.45% |
| 1997 | 23.2 Million USD | 52.63% |
| 1996 | 15.2 Million USD | 52.0% |
| 1995 | 10 Million USD | 49.25% |
| 1994 | 6.7 Million USD | 63.41% |
| 1993 | 4.1 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 1.22 Billion USD | 1.74% |
| 2024 Q2 | 307.61 Million USD | -1.11% |
| 2024 Q1 | 311.06 Million USD | -6.07% |
| 2024 Q4 | 323.04 Million USD | 5.23% |
| 2024 Q3 | 306.99 Million USD | -0.2% |
| 2023 Q2 | 291.1 Million USD | 9.82% |
| 2023 FY | 1.2 Billion USD | 17.54% |
| 2023 Q4 | 331.15 Million USD | 4.44% |
| 2023 Q1 | 265.07 Million USD | -0.76% |
| 2023 Q3 | 317.08 Million USD | 8.92% |
| 2022 Q1 | 244.37 Million USD | -1.88% |
| 2022 FY | 1.02 Billion USD | 10.5% |
| 2022 Q4 | 267.11 Million USD | 3.96% |
| 2022 Q3 | 256.93 Million USD | 0.52% |
| 2022 Q2 | 255.6 Million USD | 4.6% |
| 2021 Q1 | 221.76 Million USD | -1.93% |
| 2021 Q3 | 223.83 Million USD | -3.56% |
| 2021 FY | 926.74 Million USD | 1.98% |
| 2021 Q2 | 232.09 Million USD | 4.66% |
| 2021 Q4 | 249.05 Million USD | 11.27% |
| 2020 Q2 | 229.92 Million USD | -1.72% |
| 2020 Q4 | 226.12 Million USD | -2.6% |
| 2020 FY | 908.72 Million USD | 0.9% |
| 2020 Q3 | 232.16 Million USD | 0.97% |
| 2020 Q1 | 233.95 Million USD | -4.96% |
| 2019 Q2 | 220.53 Million USD | 10.84% |
| 2019 Q4 | 246.17 Million USD | 4.79% |
| 2019 Q1 | 198.96 Million USD | -4.38% |
| 2019 Q3 | 234.93 Million USD | 6.53% |
| 2019 FY | 900.59 Million USD | 12.31% |
| 2018 Q2 | 203.77 Million USD | 5.56% |
| 2018 FY | 801.9 Million USD | 7.64% |
| 2018 Q4 | 208.07 Million USD | 5.62% |
| 2018 Q1 | 193.04 Million USD | -1.71% |
| 2018 Q3 | 197 Million USD | -3.33% |
| 2017 Q3 | 184.37 Million USD | -2.55% |
| 2017 Q2 | 189.18 Million USD | 8.08% |
| 2017 Q4 | 196.41 Million USD | 6.53% |
| 2017 FY | 745.01 Million USD | 19.17% |
| 2017 Q1 | 175.03 Million USD | -3.26% |
| 2016 Q3 | 152.01 Million USD | 0.26% |
| 2016 Q2 | 151.61 Million USD | 7.84% |
| 2016 Q1 | 140.59 Million USD | -8.64% |
| 2016 FY | 625.16 Million USD | 4.87% |
| 2016 Q4 | 180.93 Million USD | 19.02% |
| 2015 FY | 596.16 Million USD | 3.08% |
| 2015 Q4 | 153.88 Million USD | 5.72% |
| 2015 Q3 | 145.56 Million USD | -5.53% |
| 2015 Q1 | 142.63 Million USD | -8.83% |
| 2015 Q2 | 154.07 Million USD | 8.02% |
| 2014 Q4 | 156.44 Million USD | 6.36% |
| 2014 Q2 | 143.73 Million USD | 9.64% |
| 2014 Q1 | 131.09 Million USD | -24.52% |
| 2014 FY | 578.37 Million USD | -1.27% |
| 2014 Q3 | 147.09 Million USD | 2.33% |
| 2013 Q1 | 128.15 Million USD | -6.27% |
| 2013 Q4 | 173.68 Million USD | 21.16% |
| 2013 FY | 585.83 Million USD | 11.52% |
| 2013 Q3 | 143.35 Million USD | 1.93% |
| 2013 Q2 | 140.64 Million USD | 9.74% |
| 2012 Q3 | 132.94 Million USD | 1.13% |
| 2012 Q4 | 136.73 Million USD | 2.85% |
| 2012 Q1 | 124.18 Million USD | -6.05% |
| 2012 Q2 | 131.46 Million USD | 5.86% |
| 2012 FY | 525.32 Million USD | 10.97% |
| 2011 Q2 | 116.12 Million USD | 8.98% |
| 2011 Q1 | 106.56 Million USD | -2.15% |
| 2011 FY | 473.4 Million USD | 14.88% |
| 2011 Q4 | 132.17 Million USD | -61.26% |
| 2011 Q3 | 341.22 Million USD | 193.84% |
| 2010 Q3 | 104.4 Million USD | -0.83% |
| 2010 Q2 | 105.28 Million USD | 9.08% |
| 2010 Q1 | 96.51 Million USD | 0.21% |
| 2010 FY | 412.1 Million USD | 14.48% |
| 2010 Q4 | 108.89 Million USD | 4.3% |
| 2009 Q3 | 86.42 Million USD | -1.45% |
| 2009 Q2 | 87.69 Million USD | -3.17% |
| 2009 Q1 | 90.56 Million USD | -8.61% |
| 2009 FY | 359.99 Million USD | 3.33% |
| 2009 Q4 | 96.3 Million USD | 11.44% |
| 2008 Q1 | 77.71 Million USD | -4.24% |
| 2008 FY | 348.4 Million USD | 18.37% |
| 2008 Q4 | 99.09 Million USD | 13.76% |
| 2008 Q3 | 87.1 Million USD | 3.11% |
| 2008 Q2 | 84.48 Million USD | 8.7% |
| 2007 Q1 | 65.98 Million USD | -0.66% |
| 2007 FY | 294.32 Million USD | 20.39% |
| 2007 Q3 | 76.12 Million USD | 7.12% |
| 2007 Q2 | 71.06 Million USD | 7.71% |
| 2007 Q4 | 81.15 Million USD | 6.61% |
| 2006 Q2 | 59.28 Million USD | 8.48% |
| 2006 FY | 244.47 Million USD | 46.31% |
| 2006 Q1 | 54.65 Million USD | 9.07% |
| 2006 Q4 | 66.41 Million USD | 3.58% |
| 2006 Q3 | 64.12 Million USD | 8.16% |
| 2005 Q2 | 41.81 Million USD | 24.87% |
| 2005 Q4 | 50.1 Million USD | 20.19% |
| 2005 FY | 167.08 Million USD | 27.18% |
| 2005 Q3 | 41.68 Million USD | -0.29% |
| 2005 Q1 | 33.48 Million USD | -4.56% |
| 2004 Q4 | 35.08 Million USD | 0.06% |
| 2004 Q1 | 28.2 Million USD | -11.34% |
| 2004 Q3 | 35.05 Million USD | 6.14% |
| 2004 FY | 131.37 Million USD | 24.12% |
| 2004 Q2 | 33.03 Million USD | 17.11% |
| 2003 Q1 | 22.18 Million USD | -82.51% |
| 2003 Q3 | 26.08 Million USD | 1.22% |
| 2003 Q2 | 25.76 Million USD | 16.14% |
| 2003 FY | 105.84 Million USD | -42.49% |
| 2003 Q4 | 31.81 Million USD | 21.98% |
| 2002 Q2 | 18.39 Million USD | 4.22% |
| 2002 Q4 | 126.82 Million USD | 498.21% |
| 2002 FY | 184.05 Million USD | 201.44% |
| 2002 Q3 | 21.2 Million USD | 15.27% |
| 2002 Q1 | 17.64 Million USD | -7.65% |
| 2001 Q2 | 15 Million USD | 7.63% |
| 2001 Q4 | 19.1 Million USD | 14.11% |
| 2001 FY | 61.06 Million USD | 18.03% |
| 2001 Q1 | 13.94 Million USD | -0.73% |
| 2001 Q3 | 16.74 Million USD | 11.57% |
| 2000 Q1 | 11.7 Million USD | 9.35% |
| 2000 Q2 | 12.5 Million USD | 6.84% |
| 2000 Q4 | 14.04 Million USD | 3.88% |
| 2000 Q3 | 13.52 Million USD | 8.18% |
| 2000 FY | 51.73 Million USD | 34.37% |
| 1999 Q4 | 10.7 Million USD | 16.3% |
| 1999 FY | 38.5 Million USD | 29.19% |
| 1999 Q1 | 8.8 Million USD | 7.32% |
| 1999 Q2 | 9.6 Million USD | 9.09% |
| 1999 Q3 | 9.2 Million USD | -4.17% |
| 1998 Q1 | 6.9 Million USD | 4.55% |
| 1998 Q4 | 8.2 Million USD | 5.13% |
| 1998 Q3 | 7.8 Million USD | 13.04% |
| 1998 Q2 | 6.9 Million USD | 0.0% |
| 1998 FY | 29.8 Million USD | 28.45% |
| 1997 Q2 | 5.6 Million USD | 7.69% |
| 1997 Q1 | 5.2 Million USD | 4.0% |
| 1997 Q3 | 5.9 Million USD | 5.36% |
| 1997 Q4 | 6.6 Million USD | 11.86% |
| 1997 FY | 23.2 Million USD | 52.63% |
| 1996 FY | 15.2 Million USD | 52.0% |
| 1996 Q4 | 5 Million USD | 35.14% |
| 1996 Q3 | 3.7 Million USD | 0.0% |
| 1996 Q1 | - USD | 100.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | -20.7 Million USD | 0.0% |
| 1995 FY | 10 Million USD | 49.25% |
| 1995 Q2 | - USD | 0.0% |
| 1994 FY | 6.7 Million USD | 63.41% |
| 1994 Q4 | -12.6 Million USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q4 | -7 Million USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 FY | 4.1 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -269.99% |
| Accuray Incorporated | 142.61 Million USD | -859.474% |
| Align Technology, Inc. | 2.07 Billion USD | 34.112% |
| Elevance Health Inc. | 36.23 Billion USD | 96.224% |
| AxoGen, Inc. | 149.33 Million USD | -816.305% |
| Boston Scientific Corporation | 7.5 Billion USD | 81.77% |
| CVS Health Corporation | 40.68 Billion USD | 96.637% |
| Cardinal Health, Inc. | 5 Billion USD | 72.633% |
| Centene Corporation | 138.33 Billion USD | 99.011% |
| DaVita Inc. | 1.47 Billion USD | 7.165% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 96.989% |
| Hologic, Inc. | 1.26 Billion USD | -7.95% |
| Humana Inc. | 102.36 Billion USD | 98.663% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -25.212% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | 32.306% |
| Masimo Corporation | 867 Million USD | -57.828% |
| McKesson Corporation | 8.67 Billion USD | 84.226% |
| Patterson Companies, Inc. | 1.12 Billion USD | -21.383% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | 15.008% |
| Henry Schein, Inc. | 2.93 Billion USD | 53.409% |
| Teladoc Health, Inc. | 2.09 Billion USD | 34.557% |
| Universal Health Services, Inc. | 9.2 Billion USD | 85.14% |
| Veeva Systems Inc. | 1.25 Billion USD | -8.856% |
| Baxter International Inc. | 5.27 Billion USD | 74.045% |
| Becton, Dickinson and Company | 6.71 Billion USD | 79.613% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 53.813% |
| Danaher Corporation | 8.75 Billion USD | 84.37% |
| Stryker Corporation | 9.2 Billion USD | 85.141% |
| Medtronic plc | 16.12 Billion USD | 91.516% |